Author

A. Cesar-Razquin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

E. Girardi· 3 shared G. Superti-Furga· 3 shared J. Konecka· 2 shared A. Fauster· 1 shared A. Ingles-Prieto· 1 shared A. Ringler· 1 shared C.-H. Lardeau· 1 shared F. Kartnig· 1 shared

Activity by Year

2018-2019 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCell Biology

E. Girardi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs

E. Girardi, A. Cesar-Razquin, K. Papakostas, S. Lindinger, J. Konecka, J. Hemmerich, S. Kickinger, F. Kartnig, A. Ingles-Prieto, G. Fiume, A. Ringler, C.-H. Lardeau, R. K. Kandasamy, S. Kubicek, G. F. Ecker, G. Superti-Furga

This study identifies SLC transporters critical for drug resistance using CRISPR screens in human cells, revealing widespread roles of SLCs in drug uptake and activity.

bioRxiv · Aug 8, 2019Cell Biology

In silico prioritization of transporter-drug relationships from drug sensitivity screens

A. Cesar-Razquin, E. Girardi, M. Yang, M. Brehme, J. Saez-Rodriguez, G. Superti-Furga

The paper uses pharmacogenomics data and regression models to identify drug-transporter relationships, uncovering both known and novel associations.

bioRxiv · Jul 31, 2018Pharmacology & Toxicology

Systematic genetic mapping of necroptosis identifies SLC39A7 as modulator of death receptor trafficking

A. Fauster, M. Rebsamen, K. L. Willmann, A. Cesar-Razquin, E. Girardi, J. W. Bigenzahn, F. Schischlik, S. Scorzoni, M. Bruckner, J. Konecka, K. Hörmann, L. X. Heinz, K. Boztug, G. Superti-Furga

The paper uses genetic screens to identify SLC39A7 as a modulator of necroptosis by affecting TNF receptor trafficking and ER homeostasis.

bioRxiv · Mar 29, 2018Cell Biology